UY31919A - Derivados de dibenzotiazepinas y sus usos-424 - Google Patents
Derivados de dibenzotiazepinas y sus usos-424Info
- Publication number
- UY31919A UY31919A UY0001031919A UY31919A UY31919A UY 31919 A UY31919 A UY 31919A UY 0001031919 A UY0001031919 A UY 0001031919A UY 31919 A UY31919 A UY 31919A UY 31919 A UY31919 A UY 31919A
- Authority
- UY
- Uruguay
- Prior art keywords
- dibenzotiazepinas
- derivatives
- disorder
- compounds
- schizophrenia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Compuestos de la siguiente fórmula: donde Z es como se describen en la memoria descriptiva, sales farmacéuticamente aceptables de los mismos, composiciones que los comprenden, y procedimientos para tratar el trastorno bipolar, un trastorno de ansiedad, un trastorno del humor o esquizofrenia, u otros trastornos psicóticos, con los referidos compuestos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7441708P | 2008-06-20 | 2008-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY31919A true UY31919A (es) | 2010-01-29 |
Family
ID=41431860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001031919A UY31919A (es) | 2008-06-20 | 2009-06-18 | Derivados de dibenzotiazepinas y sus usos-424 |
Country Status (38)
Country | Link |
---|---|
US (3) | US20110160184A1 (es) |
EP (1) | EP2307389B1 (es) |
JP (2) | JP5468068B2 (es) |
KR (1) | KR20110019781A (es) |
CN (1) | CN102131791B (es) |
AR (1) | AR072200A1 (es) |
AU (1) | AU2009260905B2 (es) |
BR (1) | BRPI0914231A2 (es) |
CA (1) | CA2728675A1 (es) |
CL (1) | CL2010001471A1 (es) |
CR (1) | CR11860A (es) |
CU (1) | CU23884B1 (es) |
CY (1) | CY1113845T1 (es) |
DK (1) | DK2307389T3 (es) |
DO (1) | DOP2010000393A (es) |
EA (1) | EA201001889A1 (es) |
EC (1) | ECSP10010698A (es) |
ES (1) | ES2402084T3 (es) |
HK (1) | HK1156308A1 (es) |
HN (1) | HN2010002683A (es) |
HR (1) | HRP20130234T1 (es) |
IL (2) | IL210081A (es) |
ME (1) | ME01516B (es) |
MX (1) | MX2010014203A (es) |
MY (1) | MY157518A (es) |
NI (1) | NI201000224A (es) |
NZ (1) | NZ590616A (es) |
PE (1) | PE20110029A1 (es) |
PL (1) | PL2307389T3 (es) |
PT (1) | PT2307389E (es) |
RS (1) | RS52703B (es) |
SI (1) | SI2307389T1 (es) |
SV (1) | SV2010003769A (es) |
TW (1) | TWI488854B (es) |
UA (1) | UA105903C2 (es) |
UY (1) | UY31919A (es) |
WO (1) | WO2009154563A1 (es) |
ZA (1) | ZA201100488B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2307389E (pt) * | 2008-06-20 | 2013-03-28 | Astrazeneca Ab | Derivados de dibenzotiazepina e sua utilização |
KR20160043029A (ko) * | 2013-08-12 | 2016-04-20 | 그라파이트 소프트웨어 코포레이션 | 보안 인증 및 암호화된 도메인들로의 스위칭 |
CN103524455A (zh) * | 2013-10-30 | 2014-01-22 | 苏州敬业医药化工有限公司 | 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法 |
CA2931289C (en) | 2013-11-21 | 2023-10-17 | Graphite Software Corporation | Managed domains for remote content and configuration control on mobile information devices |
CN104447615A (zh) * | 2014-02-28 | 2015-03-25 | 广东东阳光药业有限公司 | 喹硫平中间体的制备方法 |
EP4428132A1 (en) * | 2023-03-08 | 2024-09-11 | Johann-Wolfgang-Goethe-Universität Frankfurt am Main | Slack-activating compounds and their medical use |
WO2024184543A1 (en) * | 2023-03-08 | 2024-09-12 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Slack-activating compounds and their medical use |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL294355A (es) | ||||
NL293201A (es) | ||||
DE1620703B2 (de) * | 1960-08-16 | 1976-11-25 | Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern | 11-basisch substituierte dibenzo eckige klammer auf b,f eckige klammer zu-eckige klammer auf 1,4 eckige klammer zu-thiazepine |
CH422793A (de) * | 1961-07-20 | 1966-10-31 | Wander Ag Dr A | Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine |
DE1620712A1 (de) * | 1962-05-25 | 1970-06-04 | Wander Ag Dr A | Verfahren zur Herstellung 11-basisch substituierter Dibenzo-[b,f][1,4]-thiazepine |
CH476743A (de) | 1962-06-08 | 1969-08-15 | Wander Ag Dr A | Verfahren zur Herstellung von Amidinen der Dibenzo (b,e) (1,4)-diazepin-Reihe |
NL140242B (nl) | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
BE632120A (es) | 1963-05-09 | |||
US3683034A (en) | 1963-09-27 | 1972-08-08 | Upjohn Co | Process for the preparation of substituted hydroquinones |
US3884920A (en) | 1967-07-14 | 1975-05-20 | Sandoz Ag | 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines |
US3908010A (en) | 1967-03-22 | 1975-09-23 | Wander Ag Dr A | Basically substituted heterocycles as anti-emetics |
US3412193A (en) | 1965-12-13 | 1968-11-19 | American Cyanamid Co | 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility |
US3444169A (en) | 1966-01-17 | 1969-05-13 | American Cyanamid Co | Process for 11 - aminodibenz(b,f)(1,4)oxazepines and analogous thiazepines |
NL6715650A (es) | 1966-12-16 | 1968-06-17 | ||
US3852446A (en) | 1967-03-13 | 1974-12-03 | Sandoz Ag | Organic compounds in treatment of psychotic disturbances |
US3758479A (en) | 1967-03-22 | 1973-09-11 | Sandoz Ag | Nitro and sulphamoyl substituted dibenzodiazepines |
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US3962248A (en) * | 1972-04-04 | 1976-06-08 | Sandoz, Inc. | Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines |
CH569731A5 (es) * | 1972-04-04 | 1975-11-28 | Wander Ag Dr A | |
GB8607684D0 (en) | 1986-03-27 | 1986-04-30 | Ici America Inc | Thiazepine compounds |
GB8705574D0 (en) | 1987-03-10 | 1987-04-15 | Ici Plc | Preparation of thiazepine compound |
JPH04211071A (ja) * | 1990-03-05 | 1992-08-03 | Hokuriku Seiyaku Co Ltd | 多環式化合物 |
JPH0565257A (ja) | 1991-07-05 | 1993-03-19 | Hokuriku Seiyaku Co Ltd | 多環式化合物及びその用途 |
US5750566A (en) | 1994-08-12 | 1998-05-12 | Eli Lilly And Company | Synthetic excitatory amino acids |
EP0777671B1 (en) | 1994-08-24 | 2000-04-26 | Astra Aktiebolag | Spiro-azabicyclic compounds useful in therapy |
US5602121A (en) * | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | Alkyl-substituted compounds having dopamine receptor affinity |
SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
AR013184A1 (es) | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9702799D0 (sv) | 1997-07-25 | 1997-07-25 | Astra Ab | New compounds |
US6342488B1 (en) | 1998-08-18 | 2002-01-29 | Sepracor, Inc. | Phosphonorisperidone and sulforisperidone compositions and methods |
SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
CN1365279A (zh) | 1999-07-28 | 2002-08-21 | 奥斯瓦尔德·维斯 | 用于降低身体运动期间耗氧量的制剂 |
SE9903760D0 (sv) | 1999-10-18 | 1999-10-18 | Astra Ab | New compounds |
SE0002729D0 (sv) | 2000-07-20 | 2000-07-20 | Astrazeneca Ab | Novel compound form |
WO2002060870A2 (en) | 2000-11-17 | 2002-08-08 | Adolor Corporation | Delta agonist analgesics |
IL139975A0 (en) | 2000-11-29 | 2002-02-10 | Univ Ramot | Anti proliferative drugs |
KR100915263B1 (ko) | 2001-05-18 | 2009-09-03 | 아스트라제네카 아베 | 4(페닐-피페라지닐-메틸)벤즈아미드 유도체 및 통증, 불안증 또는 위장관 장애 치료를 위한 이들의 용도 |
BR0210075A (pt) | 2001-06-01 | 2004-08-17 | Astrazeneca Ab | Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa |
KR20040026680A (ko) | 2001-07-09 | 2004-03-31 | 콤비네이토릭스, 인코포레이티드 | 염증 질환 치료용 조합 |
WO2003026563A2 (en) | 2001-09-27 | 2003-04-03 | Ramot At Tel Aviv University Ltd. | Conjugated anti-psychotic drugs and uses thereof |
US7544681B2 (en) | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
ATE484508T1 (de) | 2002-04-18 | 2010-10-15 | Astrazeneca Ab | Furylverbindungen |
AU2003224545B2 (en) | 2002-04-18 | 2009-08-13 | Astrazeneca Ab | Thienyl compounds |
CA2482313A1 (en) | 2002-04-18 | 2003-10-23 | Astrazeneca Ab | Heterocyclic compounds |
SE0202465D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New compounds |
SE0202430D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New Compounds |
SE0202598D0 (sv) | 2002-09-02 | 2002-09-02 | Astrazeneca Ab | Alpha-7 Nicotinic receptor agonists and statins in combination |
WO2004026030A2 (en) | 2002-09-18 | 2004-04-01 | Fmc Corporation | Insecticidal tricyclic derivatives |
EP1578198A1 (en) * | 2002-12-20 | 2005-09-28 | Basf Aktiengesellschaft | Pesticidal dibenzo(hetero)azepine derivatives |
EP1994932A1 (en) | 2003-01-23 | 2008-11-26 | Arcadia Pharmaceuticals Inc. | Use of N-desmethylclozapine to treat human psychosis |
US7071331B2 (en) | 2003-02-22 | 2006-07-04 | Teva Pharmaceutical Industries Ltd. | Synthesis of quetiapine and pharmaceutically acceptable salts thereof |
DE10310196A1 (de) | 2003-03-06 | 2004-09-23 | Rina-Netzwerk Rna Technologien Gmbh | Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose |
EP1615904B1 (en) | 2003-04-15 | 2008-02-27 | AstraZeneca AB | Substituted benzosulphonamides as potentiators of glutamate receptors |
US20060217366A1 (en) * | 2003-07-02 | 2006-09-28 | Astrazeneca Ab | Method of treating schizophrenia and other disorders |
PL195728B1 (pl) | 2003-07-18 | 2007-10-31 | Helm Ag | Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny |
US7550454B2 (en) | 2003-12-22 | 2009-06-23 | Acadia Pharmaceuticals, Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
RU2394030C2 (ru) * | 2003-12-22 | 2010-07-10 | Акадиа Фармасьютикалз Инк. | АМИНОЗАМЕЩЕННЫЕ АНАЛОГИ ДИАРИЛ [a,d] ЦИКЛОГЕПТЕНА В КАЧЕСТВЕ МУСКАРИНОВЫХ АГОНИСТОВ И СПОСОБЫ ЛЕЧЕНИЯ ПСИХОНЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ |
US20060063754A1 (en) | 2004-09-21 | 2006-03-23 | Edgar Dale M | Methods of treating a sleep disorder |
CN101128435A (zh) | 2004-12-27 | 2008-02-20 | 阿斯利康(瑞典)有限公司 | 作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物 |
WO2006073360A1 (en) * | 2005-01-07 | 2006-07-13 | Astrazeneca Ab | NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f] [1,4] THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS |
CA2599922A1 (en) * | 2005-04-04 | 2006-10-12 | Acadia Pharmaceuticals Inc. | Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
US20070105836A1 (en) * | 2005-10-31 | 2007-05-10 | Lars Pettersson | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
JP2010514683A (ja) | 2006-12-20 | 2010-05-06 | アストラゼネカ・アクチエボラーグ | 化合物及びその使用 |
CN101605792A (zh) | 2007-02-09 | 2009-12-16 | 阿斯利康(瑞典)有限公司 | 氮杂-异吲哚酮和它们作为亲代谢性谷氨酸受体增效剂-613的用途 |
US7491871B2 (en) | 2007-04-25 | 2009-02-17 | Stine Seed Farm, Inc. | Soybean cultivar S060299 |
TW200911255A (en) | 2007-06-07 | 2009-03-16 | Astrazeneca Ab | Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841 |
TWI417100B (zh) | 2007-06-07 | 2013-12-01 | Astrazeneca Ab | 二唑衍生物及其作為代謝型麩胺酸受體增效劑-842之用途 |
PT2307389E (pt) * | 2008-06-20 | 2013-03-28 | Astrazeneca Ab | Derivados de dibenzotiazepina e sua utilização |
-
2009
- 2009-06-18 PT PT97669535T patent/PT2307389E/pt unknown
- 2009-06-18 PE PE2010001170A patent/PE20110029A1/es not_active Application Discontinuation
- 2009-06-18 TW TW098120494A patent/TWI488854B/zh not_active IP Right Cessation
- 2009-06-18 KR KR1020117001427A patent/KR20110019781A/ko not_active Application Discontinuation
- 2009-06-18 DK DK09766953.5T patent/DK2307389T3/da active
- 2009-06-18 WO PCT/SE2009/050763 patent/WO2009154563A1/en active Application Filing
- 2009-06-18 EA EA201001889A patent/EA201001889A1/ru unknown
- 2009-06-18 CA CA2728675A patent/CA2728675A1/en not_active Abandoned
- 2009-06-18 AU AU2009260905A patent/AU2009260905B2/en not_active Ceased
- 2009-06-18 RS RS20130109A patent/RS52703B/en unknown
- 2009-06-18 UA UAA201015001A patent/UA105903C2/uk unknown
- 2009-06-18 MY MYPI2010006035A patent/MY157518A/en unknown
- 2009-06-18 UY UY0001031919A patent/UY31919A/es not_active Application Discontinuation
- 2009-06-18 NZ NZ590616A patent/NZ590616A/xx not_active IP Right Cessation
- 2009-06-18 BR BRPI0914231A patent/BRPI0914231A2/pt not_active IP Right Cessation
- 2009-06-18 SI SI200930544T patent/SI2307389T1/sl unknown
- 2009-06-18 US US12/999,808 patent/US20110160184A1/en not_active Abandoned
- 2009-06-18 CN CN200980132601.5A patent/CN102131791B/zh not_active Expired - Fee Related
- 2009-06-18 ME MEP-2013-27A patent/ME01516B/me unknown
- 2009-06-18 EP EP09766953A patent/EP2307389B1/en active Active
- 2009-06-18 PL PL09766953T patent/PL2307389T3/pl unknown
- 2009-06-18 MX MX2010014203A patent/MX2010014203A/es active IP Right Grant
- 2009-06-18 ES ES09766953T patent/ES2402084T3/es active Active
- 2009-06-18 JP JP2011514540A patent/JP5468068B2/ja not_active Expired - Fee Related
- 2009-06-19 AR ARP090102240A patent/AR072200A1/es unknown
- 2009-06-19 US US12/487,725 patent/US8158618B2/en not_active Expired - Fee Related
-
2010
- 2010-12-16 IL IL210081A patent/IL210081A/en not_active IP Right Cessation
- 2010-12-17 CL CL2010001471A patent/CL2010001471A1/es unknown
- 2010-12-20 HN HN2010002683A patent/HN2010002683A/es unknown
- 2010-12-20 CR CR11860A patent/CR11860A/es unknown
- 2010-12-20 SV SV2010003769A patent/SV2010003769A/es not_active Application Discontinuation
- 2010-12-20 DO DO2010000393A patent/DOP2010000393A/es unknown
- 2010-12-20 EC EC2010010698A patent/ECSP10010698A/es unknown
- 2010-12-20 CU CU20100252A patent/CU23884B1/es not_active IP Right Cessation
- 2010-12-20 NI NI201000224A patent/NI201000224A/es unknown
-
2011
- 2011-01-19 ZA ZA2011/00488A patent/ZA201100488B/en unknown
- 2011-10-06 HK HK11110535.8A patent/HK1156308A1/xx not_active IP Right Cessation
-
2012
- 2012-04-12 US US13/445,347 patent/US8653257B2/en not_active Expired - Fee Related
-
2013
- 2013-03-19 HR HRP20130234AT patent/HRP20130234T1/hr unknown
- 2013-03-22 CY CY20131100246T patent/CY1113845T1/el unknown
- 2013-11-21 IL IL229560A patent/IL229560A/en not_active IP Right Cessation
-
2014
- 2014-01-27 JP JP2014011979A patent/JP2014098006A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31919A (es) | Derivados de dibenzotiazepinas y sus usos-424 | |
CO6612267A2 (es) | Nuevos derivados de 1,1 dióxido- 5 fenil- 2,3,4-5tetrahidro- 1,4-benzotiazepina y composiciones farmaceúticas que los comprenden | |
CR11757A (es) | Compuestos de triazina como inhibidores mtor y quinasa pi3 | |
ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
CO6460766A2 (es) | Compuestos de haloalquil heteroaril benzamida | |
SV2010003598A (es) | Derivados de tiazol usados como inhibidores de pi 3-cinasa | |
SV2010003642A (es) | Compuestos | |
GT201400031A (es) | Derivados de 2-amino-4-(piridin-2-il)-5,6-dihidro-4h-1,3-oxazina y su uso como inhibidores de bace-1 y/o bace-2 | |
NI201100166A (es) | Derivados de benzofuranilo utilizados como inhibidores de glucoquinasa | |
DOP2012000151A (es) | Nuevos compuestos triciclicos | |
UY32848A (es) | Compuestos heterocíclicos de oxima | |
NI201500134A (es) | Derivados de 2-((4-amino-3-(3-flúor-5-hidroxifenil)-1h-pirazolo[3,4-d]pirimidin-1-il) metil)-3-(2-(trifluorometil)bencil)quinazolina-4(3h)-ona y su uso como inhibidores de fosfoinositida 3-quinasas | |
UY32296A (es) | Nuevos compuestos | |
CO6351780A2 (es) | Nuevas benzamidas, su preparaccion y su uso como medicamentos | |
SV2011003809A (es) | Derivados de heteroarilo como inhibidores de dgat1 | |
AR072016A1 (es) | Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato | |
CR20150378A (es) | Compuestos tetracíclicos sustituidos con heterociclo y métodos de uso de los mismos para el tratamiento de enfermedades víricas | |
UY31159A1 (es) | Derivados de quinolina, métodos para su fabricación, composiciones farmacéuticas de los mismos y usos de los mismos | |
AR079945A1 (es) | Derivados de pirazina como inhibidores de glucogeno sintasa quinasa 3 (gsk3) | |
CO2018007278A2 (es) | Derivados de ácido aminobenzoico metaazacíclico como antagonistas de la integrina pan | |
CU24052B1 (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), y método de producción de los mismos | |
CO2017003305A2 (es) | Derivados de la amida del ácido 2-[piridin-3-il]-2,3-dihidro-benzo[1,4]dioxin-5-carboxílico o del 2-[piridin-3-il]-2,3-dihidro-benzo[1,4]dioxin-5-carbonitrilo como inhibidores de aldosterona sintasa | |
CR20150148A (es) | Azaindolinas | |
NI201100035A (es) | Agentes antifúngicos. | |
CL2012003539A1 (es) | Compuestos derivados de alquil-piperazino-fenil 4(3h)ona; composicion farmaceutica y su uso para el tratamiento de los trastornos asociados a los receptores serotoninergicos 5-ht1a y 5-ht2a, tales como depresion, ansiedad, y trastornos del sueño. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181106 |